ScholarMate
English简体中文繁體中文
客服热线:400-1616-289
登录注册
会议论文

The phase III, randomized, double-blind, placebo-controlled KEYNOTE-811 study of pembrolizumab plus trastuzumab and chemotherapy for HER2+metastatic gastric or gastroesophageal junction (mG/GEJ) adenocarcinoma

Rha, S. Y.; Kawazoe, A.; Bai, Y.; Xu, J.; Lonardi, S.; Metges, J-P.; Yanez Weber, P. E.; Wyrwicz, L. S.; Shen, L.; Ostapenko, Y. V.; Bilici, M.; Chung, H. C.; Shitara, K.; Qin, S.; van Cutsem, E.; Tabernero, J.; Li, K.; Shih, C-S.; Bhagia, P.; Janjigian, Y. Y.哈尔滨医科大学
Annual Meeting of the European-Society-for-Medical-Oncology (ESMO)2023-11DOI: 10.1016/j.annonc.2023.10.266
4阅读
引用收藏
分享
相关
加载中…
  • Pembrolizumab plus trastuzumab and chemotherapy for HER2+metastatic gastric or gastroesophageal junction (mG/ GEJ) adenocarcinoma: Survival results from the phase III, randomized, double-blind, placebo-controlled KEYNOTE-811 study
    Janjigian, Y. Y.; Kawazoe, A.; Bai, Y.; Xu, J.; Lonardi, S.; Metges, J-P.; Weber, P. E. Yanez; Wyrwicz, L. S.; Shen, L.; Ostapenko, Y. V.; Bilici, M.; Chung, H. C.; Shitara, K.; Qin, S.; Van Cutsem, E.; Tabernero, J.; Li, K.; Shih, C-S.; Bhagia, P.; Rha, S. Y.Annual Meeting of the European-Society-for-Medical-Oncology (ESMO), Barcelona, SPAIN, 2023-10-20 To 2023-10-24.
  • Additional data from the KEYNOTE-859 study of pembrolizumab plus chemotherapy versus placebo plus chemotherapy for advanced HER2-negative gastric or gastroesophageal junction (G/GEJ) cancer
    Wyrwicz, L.; Oh, D.; Weber, P.; Bai, Y.; Ryu, M.; Lee, J.; Rivera, F.; Alves, G. Vasconcelos; Garrido, M.; Shiu, K.; Fernandez, M. Gonzalez; Li, J.; Lowery, M.; Cil, T.; Cruz, F.; Qin, S.; Yin, L.; Bordia, S.; Bhagia, P.; Rha, S.
  • KEYNOTE-859 study of pembrolizumab plus chemotherapy for advanced HER2-negative gastric or gastroesophageal junction (G/GEJ) cancer: Outcomes in the protocol-specified PD-L1-selected populations
    Rha, Sun Young; Wyrwicz, Lucjan; Weber, Patricio Eduardo Yanez; Bai, Yuxian; Ryu, Min-Hee; Lee, Jeeyun; Rivera, Fernando; Alves, Gustavo Vasconcelos; Garrido, Marcelo; Shiu, Kai-Keen; Fernandez, Manuel Gonzalez; Li, Jin; Lowery, Maeve Aine; Cil, Timucin; Cruz, Felipe Melo; Qin, Shukui; Yin, Lina; Bordia, Sonal; Bhagia, Pooja; Oh, Do-YounAnnual Meeting of the American-Society-of-Clinical-Oncology (ASCO), Chicago, IL, 2023-06-02 To 2023-06-06.被引 4
查看全部 →

会议信息

会议名称
Annual Meeting of the European-Society-for-Medical-Oncology (ESMO)
会议日期
2023-12-01 至 2023-12-03
论文集名
ANNALS OF ONCOLOGY
发表日期
2023-11
起止页码
S1521-S1522
DOI
10.1016/j.annonc.2023.10.266
资助标注
Merck Sharp Dohme LLC
收录
ISTP · SCIE

作者

  • R

    Rha, S. Y. (第一作者)

  • K

    Kawazoe, A.

查看全部 20 位作者收起作者
  • B

    Bai, Y.

    harbin med univ

  • X

    Xu, J.

    chinese peoples liberat army gen hosp

  • L

    Lonardi, S.

  • M

    Metges, J-P.

  • Y

    Yanez Weber, P. E.

  • W

    Wyrwicz, L. S.

  • S

    Shen, L.

    peking univ canc hosp & inst

  • O

    Ostapenko, Y. V.

  • B

    Bilici, M.

  • C

    Chung, H. C.

  • S

    Shitara, K.

  • Q

    Qin, S.

    nanjing univ chinese med

  • v

    van Cutsem, E.

  • T

    Tabernero, J.

  • L

    Li, K.

  • S

    Shih, C-S.

  • B

    Bhagia, P.

  • J

    Janjigian, Y. Y.

    new

登录解锁更多功能

  • 收藏这篇,随时在“我的 · 收藏”找回
  • 认领你的成果,生成推广素材
  • 关注作者获取最新成果
  • 加入项目组、协同写作
注册 / 登录

产品服务

  • 科研之友
  • 创新城
  • 科创云

服务支持

  • 帮助中心
  • 隐私政策
  • 服务条款

联系方式

在线客服:【】
客服热线:400-1616-289
电子邮箱:support@scholarmate.com

关注或下载科研之友

微信二维码
微信公众号
客户端下载二维码
下载客户端
科研成果科研人员科研机构科研动态爱瑞思软件

©2026 深圳市科研之友网络服务有限公司

公安备案图标粤公网安备 44030502000213
粤ICP备 16046710 号粤B2-20110417